The Epoch Times
The Epoch Times
Focus

US Drug Price

Weight Loss
Weight Loss
|
George Citroner

Ozempic, Wegovy, and Mounjaro: A Bargain or Too Expensive?

While Ozempic, Wegovy, and Mounjaro have gained attention for their significant weight loss effects, the drugs’ domestic cost has raised some eyebrows.
Oct 28, 2023
|
George Citroner
FacebookXTruthGettrLinkedInTelegramEmail
Ozempic, Wegovy, and Mounjaro: A Bargain or Too Expensive?
Oct 28
|
FacebookXTruthGettrLinkedInTelegramEmail
Economic Policies
Economic Policies
|
Reuters

AstraZeneca CEO Warns New US Drug Price Law Will Hurt Innovation

Aug 27, 2022
|
Reuters
FacebookXTruthGettrLinkedInTelegramEmail
AstraZeneca CEO Warns New US Drug Price Law Will Hurt Innovation
Aug 27
|
FacebookXTruthGettrLinkedInTelegramEmail
Weight Loss
Weight Loss
|
George Citroner

Ozempic, Wegovy, and Mounjaro: A Bargain or Too Expensive?

While Ozempic, Wegovy, and Mounjaro have gained attention for their significant weight loss effects, the drugs’ domestic cost has raised some eyebrows.
Oct 28, 2023
|
George Citroner
FacebookXTruthGettrLinkedInTelegramEmail
Ozempic, Wegovy, and Mounjaro: A Bargain or Too Expensive?
Oct 28
|
FacebookXTruthGettrLinkedInTelegramEmail
Economic Policies
Economic Policies
|
Reuters

AstraZeneca CEO Warns New US Drug Price Law Will Hurt Innovation

Aug 27, 2022
|
Reuters
FacebookXTruthGettrLinkedInTelegramEmail
AstraZeneca CEO Warns New US Drug Price Law Will Hurt Innovation
Aug 27
|
FacebookXTruthGettrLinkedInTelegramEmail
home-iconepochtv-iconhealth-iconbright-iconepochfun-icon
The Epoch Times
To ensure we reach the high standards of reliability and neutrality that you expect from us, we are engaging with Ad Fontes Media to analyze our content. If you find an article you think falls short of the standard, please submit the link through this form.
Copyright © 2000 - 2025 The Epoch Times Association Inc. All Rights Reserved.